A detailed history of Ardsley Advisory Partners LP transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ardsley Advisory Partners LP holds 352,900 shares of TEVA stock, worth $7.8 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
352,900
Previous 250,750 40.74%
Holding current value
$7.8 Million
Previous $4.07 Million 56.09%
% of portfolio
1.13%
Previous 0.67%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.81 - $18.96 $1.61 Million - $1.94 Million
102,150 Added 40.74%
352,900 $6.36 Million
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $3.2 Million - $4.36 Million
250,750 New
250,750 $4.07 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ardsley Advisory Partners LP Portfolio

Follow Ardsley Advisory Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Ardsley Advisory Partners LP with notifications on news.